RSS   Newsletter   Contact   Advertise with us
Post Online Media

Insys Therapeutics fires COO Dan Brennan

Insys TherapeuticsInsys Therapeutics said that Dan Brennan, executive vice president and chief operating officer, was terminated.
Article continues below

READ MORE Edge Therapeutics appoints chief operating officer

Mr. Brennan became Company's Executive Vice President and Chief Operating Officer in November 2015.

Prior to Mr. Brennan joining Insys, he was Vice President and Group General Manager of Lundbeck LLC’s Neurology Business Unit and U.S. Business Development group.

Before that, he worked at Abbott Laboratories where he lead Abbott’s Hospital Product Pharmaceutical group.

Mr. Brennan has sales, marketing and new product development expertise from his decade of service at Eli Lilly and Company.

Mr. Brennan serves on the Board of Directors of the Illinois Biotechnology Industry Organization (iBIO) and the Executive Board of Directors for Court Appointed Special Advocates (CASA) in Lake County, IL.

He received a B.A. from the University of Notre Dame and an MBA degree from the Kellogg Graduate School of Business at Northwestern University.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy